Robert Eferl
Comprehensive Cancer Center Vienna · 142 works · 9,367 citations · h-index 40
Top works
- AP-1: a double-edged sword in tumorigenesis
- Liver Tumor Development
- Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins
- Functions of c-Jun in Liver and Heart Development
- Fos/AP‐1 proteins in bone and the immune system
- c-Jun Regulates Eyelid Closure and Skin Tumor Development through EGFR Signaling
- Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects
- Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease
- Stat3 Is a Negative Regulator of Intestinal Tumor Progression in ApcMin Mice
- The Fos‐related antigen Fra‐1 is an activator of bone matrix formation
- c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity
- Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia
- Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1
- Hepatic tumor–stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge
- Gene 19 of plasmid R1 is required for both efficient conjugative DNA transfer and bacteriophage R17 infection
- Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis
- PDGFR blockade is a rational and effective therapy for NPM-ALK–driven lymphomas
- The AP1 transcription factor Fra2 is required for efficient cartilage development
- STAT3 regulated ARF expression suppresses prostate cancer metastasis
- Cancer-associated fibroblast-derived WNT2 increases tumor angiogenesis in colon cancer